+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Sorafenib"

Sorafenib Market Report 2024 - Product Thumbnail Image

Sorafenib Market Report 2024

  • Report
  • December 2024
  • 175 Pages
  • Global
From
Kidney Cancer Drugs Market Report 2025 - Product Thumbnail Image

Kidney Cancer Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
From
Advanced Merkel cell carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced Merkel cell carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 80 Pages
  • Global
From
Renal Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Renal Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 180 Pages
  • Global
From
Research Report on China's Sorafenib Market, 2021-2025 - Product Thumbnail Image

Research Report on China's Sorafenib Market, 2021-2025

  • Report
  • September 2021
  • 40 Pages
  • China
From
Nexavar (Sorafenib) - Drug Insight and Market Forecast - 2030 - Product Thumbnail Image

Nexavar (Sorafenib) - Drug Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
From
From
Nexavar (sorafenib; Bayer/Amgen) Drug Overview 2019 - Product Thumbnail Image

Nexavar (sorafenib; Bayer/Amgen) Drug Overview 2019

  • Report
  • September 2019
  • 28 Pages
  • Global
Inlyta (axitinib; Pfizer) Drug Overview 2019 - Product Thumbnail Image

Inlyta (axitinib; Pfizer) Drug Overview 2019

  • Report
  • March 2019
  • 20 Pages
  • Global
  • 14 Results (Page 1 of 1)
Loading Indicator

Sorafenib is a drug used to treat advanced skin cancer. It is a type of targeted therapy, meaning it works by targeting specific molecules involved in the growth and spread of cancer cells. It is used to treat advanced melanoma, a type of skin cancer, and is also used to treat other types of cancer, such as kidney and liver cancer. Sorafenib works by blocking the action of certain proteins that are involved in the growth and spread of cancer cells. It is usually taken in pill form, and is usually taken twice a day. Sorafenib is a relatively new drug, and is still in the early stages of development. It is not yet widely available, and is only approved for use in certain countries. However, it is becoming increasingly popular as a treatment for advanced skin cancer, and is being studied for use in other types of cancer. The Sorafenib market is highly competitive, with many companies vying for a share of the market. Some of the major players in the market include Bayer, Novartis, Pfizer, and Merck. Other companies in the market include GlaxoSmithKline, AstraZeneca, and Eli Lilly. Show Less Read more